A Study to Assess the Safety and Efficacy of Vatiquinone in Participants With Friedreich Ataxia
Clinical trial NCT05515536 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05515536
- Sponsor
- PTC Therapeutics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-08
- Primary completion
- 2027-12-31
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.